Free Trial Information
BioCentury | Sep 14, 2017
Company News

Management tracks: SymCel, Taro, Akcea

...neurology company Intellipharmaceutics International Inc. (TSX:IPCI; NASDAQ:IPCI) named Andrew Patient CFO. He was CFO at Merus Labs International Inc....
...officer. Jennie Walters Aeterna Zentaris Inc. Akcea Therapeutics Inc. Artios Pharma Ltd. AstraZeneca plc Biogen Inc. BioLamina AB Eyevensys S.A.S. Intellipharmaceutics International Inc. Kane Biotech Inc. Merus Labs International Inc. Norgine...
Read More
BioCentury | Mar 7, 2016
Financial News

Merus Labs International completes private placement

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date completed: 2016-03-01 Type: Private placement Raised: C$27.1 million ($20 million) Shares: 14.3 million Price: C$1.90 Shares after offering: 116.8 million Note: Merus Labs...
Read More
BioCentury | Feb 29, 2016
Financial News

Merus Labs International proposes private placement

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date announced: 2016-02-19 Type: Private placement To be raised: Up to C$27.1 million ($19.7 million) Shares: 14.3 million Price: C$1.90 Shares outstanding prior: 102.6...
Read More
BioCentury | Jul 13, 2015
Finance

Tiers, some fears

...$120.00 $1,475.0 $2,070.8 40% ProMetic Life Sciences Inc. (TSX:PLI; OTCQX:PFSCF) 4/14/15 $45.73 $1,187.2 $1,102.2 -7% Merus Labs International Inc....
Read More
BioCentury | Jun 8, 2015
Financial News

Merus Labs International financial update

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date announced: 2015-06-01 Note: Merus raised C$3.1 million ($2.4 million) through the sale of 1 million shares at C$3.05 to cover the overallotment from...
Read More
BioCentury | Apr 20, 2015
Financial News

Merus Labs International completes follow-on

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date completed: 2015-04-13 Type: Follow-on Raised: C$60 million ($47.5 million) Shares: 19.7 million Price: C$3.05 Shares after offering: 101 million Underwriters: Clarus Securities; Cormark...
Read More
BioCentury | Apr 15, 2015
Financial News

Merus Labs raises C$60M in bought deal

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI) raised C$60 million (US$47.5 million) on Monday through the sale of 19.7 million shares at C$3.05 to underwriters in a bought deal. Clarus Securities; Cormark Securities; Canaccord Genuity; Laurentian...
Read More
BioCentury | Dec 22, 2014
Company News

Merus Labs International management update

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Transitioned: Barry Fishman to CEO from interim CEO WIR Staff Dermatology Infectious...
Read More
BioCentury | Sep 29, 2014
Company News

Merus Labs International management update

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Resigned: Elie Farah as CEO and a director; Senior Advisor Barry Fishman becomes interim CEO and a director WIR Staff Dermatology Infectious...
Read More
BioCentury | Sep 8, 2014
Company News

Merus Labs International, Dacha Strategic Metals deal

...halted trading on the Toronto Stock Exchange-Venture on Aug. 13 and delisted on Aug. 20. Merus Labs International Inc....
Read More
Items per page:
1 - 10 of 31
BioCentury | Sep 14, 2017
Company News

Management tracks: SymCel, Taro, Akcea

...neurology company Intellipharmaceutics International Inc. (TSX:IPCI; NASDAQ:IPCI) named Andrew Patient CFO. He was CFO at Merus Labs International Inc....
...officer. Jennie Walters Aeterna Zentaris Inc. Akcea Therapeutics Inc. Artios Pharma Ltd. AstraZeneca plc Biogen Inc. BioLamina AB Eyevensys S.A.S. Intellipharmaceutics International Inc. Kane Biotech Inc. Merus Labs International Inc. Norgine...
Read More
BioCentury | Mar 7, 2016
Financial News

Merus Labs International completes private placement

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date completed: 2016-03-01 Type: Private placement Raised: C$27.1 million ($20 million) Shares: 14.3 million Price: C$1.90 Shares after offering: 116.8 million Note: Merus Labs...
Read More
BioCentury | Feb 29, 2016
Financial News

Merus Labs International proposes private placement

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date announced: 2016-02-19 Type: Private placement To be raised: Up to C$27.1 million ($19.7 million) Shares: 14.3 million Price: C$1.90 Shares outstanding prior: 102.6...
Read More
BioCentury | Jul 13, 2015
Finance

Tiers, some fears

...$120.00 $1,475.0 $2,070.8 40% ProMetic Life Sciences Inc. (TSX:PLI; OTCQX:PFSCF) 4/14/15 $45.73 $1,187.2 $1,102.2 -7% Merus Labs International Inc....
Read More
BioCentury | Jun 8, 2015
Financial News

Merus Labs International financial update

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date announced: 2015-06-01 Note: Merus raised C$3.1 million ($2.4 million) through the sale of 1 million shares at C$3.05 to cover the overallotment from...
Read More
BioCentury | Apr 20, 2015
Financial News

Merus Labs International completes follow-on

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date completed: 2015-04-13 Type: Follow-on Raised: C$60 million ($47.5 million) Shares: 19.7 million Price: C$3.05 Shares after offering: 101 million Underwriters: Clarus Securities; Cormark...
Read More
BioCentury | Apr 15, 2015
Financial News

Merus Labs raises C$60M in bought deal

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI) raised C$60 million (US$47.5 million) on Monday through the sale of 19.7 million shares at C$3.05 to underwriters in a bought deal. Clarus Securities; Cormark Securities; Canaccord Genuity; Laurentian...
Read More
BioCentury | Dec 22, 2014
Company News

Merus Labs International management update

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Transitioned: Barry Fishman to CEO from interim CEO WIR Staff Dermatology Infectious...
Read More
BioCentury | Sep 29, 2014
Company News

Merus Labs International management update

Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Resigned: Elie Farah as CEO and a director; Senior Advisor Barry Fishman becomes interim CEO and a director WIR Staff Dermatology Infectious...
Read More
BioCentury | Sep 8, 2014
Company News

Merus Labs International, Dacha Strategic Metals deal

...halted trading on the Toronto Stock Exchange-Venture on Aug. 13 and delisted on Aug. 20. Merus Labs International Inc....
Read More
Items per page:
1 - 10 of 31